Skip to Content
Upcoming Events
There are no upcoming events available at this time.
Past Events
Jun 21, 2022 at 2:16 PM CEST
Round table: Pasquale Frega (Country President & Pharma Head at Novartis), Jodi Halpern (MD, PhD Professor of Bioethics and Ethics of Innovative Technologies, University of California, Berkeley), Pierluigi Paracchi (Co-founder & CEO at Genenta).
Jun 15, 2022 from 5:30 PM to 7:30 PM BST

Speakers:
MC Carolina Neri, Director at Finsbury Glover Hering
Massimo Carnelos, Head of the Economic Office of the Embassy of Italy in London
Giancarlo Rocchietti, Founder and President at Club degli Investitori
Andrea Rota, Managing Director at Club degli Investitori
Gioia Manetti, Member at Club degli Investitori

 

Keynote speakers:
Luca Rossettini, founder and CEO at D-Orbit
Pierluigi Paracchi, founder and CEO at Genenta
Stefano Buono, founder and CEO at Newcleo

One Great George Street, Westminster, London SW1P 3AA
Jun 10, 2022 at 4:30 PM CEST to May 10, 2022 at 10:45 PM CEST
Title: Using Gene-Modified Autologous Stem Cells Progeny to Reeducate the Tumor Immune Microenvironment of Solid Tumors (TEM-GBM Study)
Type: Poster presentation
Time: June 10, 2022, 4:30 PM - 4:45 PM CEST
Vienna and virtual
Jun 5, 2022 from 8:00 AM to 11:00 AM EDT
Title: Harnessing genetically engineered hematopoietic progenitor cells to redirect the tumor immune microenvironment against glioblastoma (TEM-GBM Study)
Type: Poster presentation
Berlin
May 31, 2022 at 11:00 AM CEST

EuropaBio - the European Association for Bioindustries, round table discussion within SME Bioforum about the business environment for Advanced Therapy Medicinal Products (ATMPs) in Europe

 

The Meeting is online and invitation only.

 

Speaker Pierluigi Paracchi, CEO and Co-Founder Genenta Science

May 18, 2022 at 11:00 AM EDT

Speaker: Pierluigi Paracchi CEO and Co-founder; Carlo Russo Carlo Russo - Chief Medical Officer & Head of Development

In person event at the InterContinental Barclay NY

Webcasting information: Fireside chats will be webcasted via Open Exchange. Additional details will be provided closer to the conference.